Maria Fleseriu

Professor

  • 1895 Citations
  • 21 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Pituitary ACTH Hypersecretion Medicine & Life Sciences
Acromegaly Medicine & Life Sciences
Pituitary Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cushing Syndrome Medicine & Life Sciences
Hydrocortisone Medicine & Life Sciences
Growth Hormone Medicine & Life Sciences
Adrenal Insufficiency Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 1895 Citations
  • 21 h-Index
  • 84 Article
  • 12 Review article
  • 7 Chapter
  • 7 Editorial

Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas

Ioachimescu, A. G., Fleseriu, M., Hoffman, A. R., Vaughan, T. B. & Katznelson, L., Jan 1 2019, In : European journal of endocrinology. 180, 1, p. 31-40 10 p.

Research output: Contribution to journalArticle

Hyperprolactinemia
Dopamine Agonists
Prolactin
Adenoma
Psychology

Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update

Gadelha, M. R., Kasuki, L., Lim, D. S. T. & Fleseriu, M., Feb 1 2019, In : Endocrine reviews. 40, 1, p. 268-332 65 p.

Research output: Contribution to journalArticle

Acromegaly
Mortality
Therapeutics
Diabetes Complications
Insulin-Like Growth Factor I
2 Citations

Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study

Liu, W., Zahr, R. S., McCartney, S., Cetas, J., Dogan, A. & Fleseriu, M., Jun 23 2018, (Accepted/In press) In : Pituitary. p. 1-9 9 p.

Research output: Contribution to journalArticle

Prolactinoma
ACTH-Secreting Pituitary Adenoma
Residual Neoplasm
Pituitary Neoplasms
Optic Chiasm
11 Citations

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

for the & Pasireotide G2304 Study Group, Jan 1 2018, In : The Lancet Diabetes and Endocrinology. 6, 1, p. 17-26 10 p.

Research output: Contribution to journalArticle

Pituitary ACTH Hypersecretion
Clinical Trials
Safety
Hydrocortisone
pasireotide
Central Nervous System Cysts
Adrenal Insufficiency
Headache
Recurrence
Cysts